Professor Shahina Pardhan to lead new vision research unit

Article

Professor Shahina Pardhan has been appointed director of Anglia Ruskin University's new Vision and Eye Research Unit (VERU).

Professor Shahina Pardhan has been appointed director of Anglia Ruskin University’s new Vision and Eye Research Unit (VERU).

Professor Pardhan has an extensive background in optometry and research based on the clinical assessment of visual functions in range of normal and abnormal ocular conditions including myopia, low vision and normal vision. She was the first woman to become Professor of Optometry at Anglia Ruskin University and has been awarded the Asian Jewel Award (Health care and education category) and the Asian Women of Achievement award.

Talking to the Cambridge Network she said: "I am really looking forward to this exciting new venture and working with vision and eye researchers both within Anglia Ruskin and externally. We have an outstanding team here, offering world-leading expertise which is already proving attractive to organisations seeking to fulfil their research and development needs."

VERU will build on existing collaborations and build new research partnerships both in- and outside the university, including the NHS and partners in the optical and pharmaceutical industries. Other experts involved with the unit include Professor Rupert Bourne, Professor of Ophthalmology at Anglia Ruskin, Professor Roger Buckley, Professor of Ocular Medicine at Anglia Ruskin and Dr Sarah Waugh, Reader in the Department of Optometry and Ophthalmic dispensing at Anglia Ruskin.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.